
NCI-designated & Comprehensive. Research, clinical trials, transformative care, survivorship, public-policy changing discoveries. #DeliveringDiscoveries
San Diego, California
Joined December 2021
- Tweets1.7K
- Following235
- Followers1.1K
- Likes980
This Movember, we're highlighting research that is changing how testicular cancer is detected and monitored.
Aditya Bagrodia, MD, a Moores Cancer Center member and urologic oncologist at UC San Diego Health, helped develop the first mRNA blood test for testicular cancer to become available in the United States.
Developed through a decade of research, the test offers a less-invasive approach to detecting and monitoring testicular cancer, helping physicians make more informed, personalized treatment decisions while potentially reducing the need for repeated CT imaging.
As we recognize Movember and its focus on men's health, this advancement underscores the importance of continued research, early detection and improving care for people affected by testicular cancer.
Learn more:
Read about this advancement: bit.ly/4t1aaT0
Watch Dr. Bagrodia discuss his work: bit.ly/4iWHhTo
#Movember #TesticularCancer #MensHealth #CancerResearch #MooresCancerCenter
5
64
Congratulations to Moores member Leslie Crews, PhD, on her TEDxSanDiego Salon: Believe in Breakthroughs talk, “Cancer as an Ecosystem,” now available on YouTube.
Drawing on ecology, stem cell biology and cancer research, Dr. Crews presents a framework for understanding cancer not only as tumor cells to be destroyed, but as a disrupted ecosystem that may be restored. She discusses findings in blood cancer research, immune aging and next-generation therapies, and how rebuilding cellular ecosystems could inform the future of cancer treatment.
Watch the full talk: lnkd.in/g_iMscBy
#MooresCancerCenter #TEDxSanDiego #CancerResearch
In this episode of “The Science Of,” Nicolas Lopez-Galvez, PhD discusses how environmental exposures may affect health across the lifespan and why strong community partnerships and clear science communication matter.
Listen Now: bit.ly/4iNKjJR
36
Moores Cancer Center member Gene Yeo, PhD, co-led a study published in Nature Communications that mapped how the SARS-CoV-2 genome interacts with key viral proteins.
The findings identified interactions that, when blocked, reduced viral replication in animal and human lung cells, suggesting potential treatments that could remain effective as coronaviruses evolve.
Read more: bit.ly/4BPFIPP
94
Danielle Glorioso, executive director of the UC San Diego Stein Institute for Research on Aging, received multidisciplinary care for advanced colorectal cancer at Moores Cancer Center at UC San Diego Health. Following radiation, chemotherapy and surgery, she learned she was cancer-free.
Now, she's sharing her story to raise awareness about cancer prevention and early detection. She recently joined Samir Gupta, MD, and Bassel El-Rayes, MD, for a lecture on cancer and aging, highlighting the importance of screening and research.
Her experience underscores the importance of initiatives like PREDICT at Moores Cancer Center, which is advancing innovative approaches to cancer prevention and early detection, including for colorectal cancer.
We're grateful to Peter Vu, MD; Michael Sherer, MD; and Nicole Lopez, MD, for their compassionate care, and to Danielle for sharing her story.
Read more: bit.ly/4zi6fmz
75
In this special episode of “The Science Of,” students Max and Zahra are joined in the studio by partners from the Elementary Institute of Science (EIS) and Moores Cancer Center to reflect on their experiences in the program.
Listen Now: bit.ly/3U9LEm0
52
People Behind the Mission Spotlight: Meet Ann Valentine!
As Manager for Oncology Supportive Care at Moores Cancer Center, Ann oversees Patient Navigation, Patient and Family Support Services, and the Resource Centers at Moores and the McGrath Outpatient Pavilion. Her work helps ensure patients and families have the guidance and support they need through every stage of their cancer journey.
Get to know Ann in this Q&A: bit.ly/4f9OMFr
#PeopleBehindTheMission #MooresCancerCenter #UCSanDiego #PatientNavigation #OncologySupportiveCare #CancerSupport
59
Haydee Ojeda-Fournier, MD, FACR, FSBI, Grillo-Marxuach Family Endowed Medical Director in Breast Imaging, is featured in RSNA News on breast cancer screening during pregnancy and lactation.
As senior author of a recent RadioGraphics article, she notes that digital mammography can be safely performed throughout pregnancy and lactation and that biopsy should not be delayed.
Read more: bit.ly/4zqeRZ0
#BreastCancer #BreastImaging #RSNA #MooresCancerCenter
1
131
This Pancreatic Cancer Awareness Month, meet Shanna Thomas, whose participation in the PRECEDE early detection initiative at Moores Cancer Center helped identify precancerous changes before they became invasive cancer.
Read her story: bit.ly/4vVLITA
#PancreaticCancerAwarenessMonth
45
Moores Cancer Center member Samir Gupta, MD, Sam. M. Walton Endowed Chair in Cancer Research, is an author on a new @NEJMEvidence report using SEER data. It found that U.S. colorectal cancer incidence rose from 36.7 to 38.3 per 100,000 between 2022 and 2023, the first apparent increase since 2000. The authors call for continued surveillance.
Read more: bit.ly/4z5ohs1
#ColorectalCancer #CancerResearch #MooresCancerCenter
1
89
Meet Moores Member Dr. Aditya Bagrodia, Professor of Urology and Radiation Oncology and Genitourinary Oncology Disease Team Leader at UC San Diego.
Dr. Bagrodia leads complex, multidisciplinary care for all urologic malignancies, with a research focus on germ cell tumors, spanning basic, translational, and clinical science. He chairs the ECOG testicular cancer working group and serves on the NCCN testicular cancer guidelines panel.
Beyond the clinic and lab, he volunteers his time to organize patient-facing summits for people affected by prostate, bladder, testicular, and kidney cancers.
Thank you, Dr. Bagrodia, for your commitment to patients and progress in cancer care!
Watch video: bit.ly/4ixNmp4
#MooresCancerCenter #UCSanDiego #MooresMember #Urology #GenitourinaryOncology #TesticularCancer #CancerResearch #PatientCare
1
128
Moores Cancer Center Director Diane Simeone, MD, is one of nine oncology leaders featured in Becker’s Hospital Review on what it will take for cancer vaccines to become standard care.
Her comments follow phase 3 results showing a personalized mRNA vaccine cut the risk of recurrence or death in high-risk melanoma by 42% when added to immunotherapy.
Dr. Simeone says advancing validation will require additional investment, and that comparing personalized and off-the-shelf approaches will be important for assessing performance, economics, and reach into community care.
Read more: bit.ly/4z5o1t3
50
November is Lung Cancer Awareness Month. Early detection can make a difference in lung cancer care 🫁
Mark Onaitis, MD, a thoracic surgeon at @UCSDHealth and a Moores Cancer Center member, shares why lung cancer screening matters.
Watch the video: youtube.com/watch?v=RIZBjFLx…
In this episode of the Science Of Podcast, Moores Member Svasti Haricharan, PhD, associate professor at San Diego State University, discusses how her lab studies the ways age, sex and socioeconomic stress shape cancer biology and treatment response.
Listen now: bit.ly/3WcsLPQ
1
69
Moores nurse practitioner Dallas Gallagher, DNP, FNP-C, AOCNP, is co-first author of a manuscript in The Oncologist establishing the first U.S. multidisciplinary consensus on pancreatic enzyme replacement therapy (PERT) for patients with pancreatic cancer. The recommendations aim to improve nutrition, quality of life and treatment continuity.
Read more: bit.ly/4svQRBl
Poison drummer Rikki Rockett credits Moores Cancer Center at UC San Diego Health with saving his life. As covered by FOX News and WKTV, a clinical trial at Moores put his stage 4 throat cancer into remission, and Moores Member Catriona Jamieson, MD, PhD, later treated his chronic myeloid leukemia, which has been in remission for many years.
Learn more about his journey: bit.ly/4z90b0d
1
69
The Testicular Cancer Patient Summit brings patients and specialists together for an interactive evening of conversation and connection.
📅 Thursday, Nov. 19
🕕 6 to 8:30 p.m.
📍 Ballast Point, Little Italy
Attendees will have the chance to engage with leading specialists and connect with peers in a comfortable social setting. Whether you are newly diagnosed, in treatment or in survivorship, this event is designed to support patients through discussion, community and access to expert insight.
Register: bit.ly/4dYhRn0
#TesticularCancer #CancerCare #PatientSupport #MooresCancerCenter #UCSanDiegoHealth @AdityaBagrodia
New episode: The Science of Oncofertility and Reproductive Health with Moores member Irene Su, MD, MSCE.
In this episode, Moores Member Irene Su, reproductive endocrinologist and fertility specialist, explains how oncofertility helps young cancer patients understand and protect their reproductive health.
Listen Now: bit.ly/3WDBP0b

ALT This image is a promotional graphic for a podcast. It features logos of UC San Diego Moores Cancer Center and the Jackie Robinson Family YMCA. The text reads: "Moores Cancer Center and the Jackie Robinson Family YMCA present: The Science of Podcast with Irene Su, MD, MSCE." There is an icon of a microphone on the right side. The background has a gradient of blue to yellow.
1
67
Join the Cancer Health Equity Collaborative (CHEC) for a Community Building Mixer on Thursday, Nov. 5, 11:30 a.m. to 1:30 p.m. at Moores Cancer Center. Let’s strengthen our shared mission to expand access to cancer care and support across San Diego and Imperial Counties.
RSVP Here: bit.ly/3VMMyFt
#CancerHealthEquity #CHEC #MooresCancerCenter
1
70
Moores Cancer Center members J. Silvio Gutkind, PhD, Uri Manor, PhD, and Johannes Schöneberg, PhD, contributed to a study published in Cell Reports revealing how the COX2-PGE2-PKA pathway suppresses the body's antiviral immune response.
Using herpes simplex virus type 1 infection as a model, researchers found that PGE2 promotes the removal of damaged mitochondria, reducing the mitochondrial DNA signals that activate STING, a key component of the body's innate immune defenses.
The findings shed light on a mechanism that limits inflammation and could inform future strategies to enhance immune responses, including cancer immunotherapy.
Read the study: bit.ly/4se5Y29
#CellReports #Immunology #STING #CancerResearch #MooresCancerCenter
3
96



















